U.S. Diversified Financial Stock News

QuidelOrtho (QDEL) is back in focus after filing a shelf registration for up to 1,000,000 shares of common stock. This ESOP-related move puts potential equity issuance on investors' radar. See our latest analysis for QuidelOrtho. At a share price of US$18.24, QuidelOrtho has seen a 30-day share price return of 29.18% and a 90-day share price return of 43.51%, yet the year-to-date share price return is down 36.62% and the 3-year total shareholder return has declined 78.49%. This suggests that...

After an 89.0% total return over the past five years, Webster Financial now sits around US$76, raising a clear valuation question: the Excess Returns intrinsic value model points to meaningful upside, while the broader checks suggest the stock is not an obvious bargain or a clear outlier. Webster Financial has delivered 89.0% over five years, which puts current buyers in the position of judging whether a strong run has already captured most of the available upside. Future revenue and profit...

Multiple U.S. states have escalated their antitrust fight against the proposed Paramount and Warner Bros. Discovery merger, with 12 states filing lawsuits to block the deal. A separate Paramount shareholder lawsuit alleges David and Larry Ellison arranged an illegal side agreement with a former U.S. president to secure regulatory approval. These actions raise fresh regulatory, legal, and reputational questions for Warner Bros. Discovery, ticker NasdaqGS:WBD, and could affect the outcome of...

Founder led companies can appeal when inflation, interest rates and growth signals are pulling in different directions, because leadership is often financially and reputationally tied to long term outcomes. With central banks adjusting policy, bond yields shifting and trade and energy trends in focus, many investors are looking for businesses where decision makers have real skin in the game. This Founder Led Companies screener aims to surface stocks where leadership is closely aligned with...

Kaiser Aluminum stock has delivered a 127.7% total return over the past three years, yet current valuation checks suggest it no longer looks like an obvious bargain. The Discounted Cash Flow (DCF) intrinsic value estimate points to a price that is roughly in line with where the shares trade today. After such a strong run, the core question for investors is whether recent growth expectations and operational progress are already well reflected in the current price. The 127.7% return over three...

Ambiq Micro (NYSE:AMBQ) has completed an upsized public equity offering, including the full exercise of the underwriters' overallotment option. The transaction brings in additional capital to the company, expanding its financial resources beyond the initial deal size. This capital raise represents a fresh development for shareholders, with potential implications for Ambiq Micro's growth plans and balance sheet flexibility. Ambiq Micro enters this new phase of funding with shares last...

In recent days, Frontline has drawn increased market attention as heightened trading and options activity coincided with new developments in its global shipping operations, boosting its visibility across the NYSE Composite. This renewed focus on Frontline’s role in worldwide tanker shipping underscores how shifts in seaborne trade patterns can quickly reframe investor interest in the company’s core business. Building on this heightened trading and options activity, we’ll now examine how...

Tapestry stock is coming off a striking run over the past five years, yet its valuation checks now point to a company that no longer looks obviously cheap, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model sitting close to the current share price while traditional multiples lean expensive. Tapestry has delivered a 311.2% return over 5 years, which means anyone holding through that period has already seen a very large amount of value recognized by the market. Future...

First Horizon (FHN) opened Q2 2026 with total revenue of US$871 million and basic EPS of US$0.55, alongside trailing 12 month net income of US$1.03 billion and EPS of about US$2.11. Over recent quarters the company has seen revenue move from US$800 million in Q2 2025 to US$894 million in Q3 2025, US$888 million in Q4 2025, US$847 million in Q1 2026 and now US$871 million. Over the same period, quarterly basic EPS stepped from US$0.46 to US$0.50, US$0.52, US$0.54 and US$0.55. With net margin...

Innovative Industrial Properties stock is trading near a 52 week high while both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples point to the shares screening as undervalued. This sits in tension with a 5 year return that has declined 52.1%. Over the past 5 years, Innovative Industrial Properties has delivered a 52.1% decline, so the recent strength comes against a weak longer term share price record. Recent news around fresh senior and exchangeable note...

Eli Lilly has signed a definitive agreement to acquire psychedelic drug developer AtaiBeckley (NasdaqGM:ATAI). The deal includes upfront cash plus contingent value rights tied to milestones in AtaiBeckley’s BPL-003 and VLS-01 depression programs. The transaction centers on late stage psychedelic therapies targeting treatment resistant forms of depression. AtaiBeckley focuses on psychedelic based therapies for mental health, with BPL-003 and VLS-01 in development for depression indications...

Weaker earnings and declining revenue at Papa John's International (PZZA) have drawn investor attention to the stock. The latest results highlight questions around demand, efficiency, and the health of its franchise system. See our latest analysis for Papa John's International. The recent quarterly miss comes after a mixed period for Papa John's International, with the share price up 4.92% over the last day but down 10.04% over three months and the 1 year total shareholder return declining...

RH recently launched RH Estates at the ultra-high end of home design, opened RH London, The Gallery in Mayfair, and entered a multi-year collaboration with the Mercedes-AMG PETRONAS Formula One Team to curate luxury interiors across the team’s global hospitality footprint. Together, these moves push RH deeper into the global luxury ecosystem by combining ultra-premium product lines, a flagship presence in a top European fashion district, and exposure to affluent Formula One audiences. We’ll...

Xylem stock has delivered a 14.5% gain over the past three years. At around US$125 per share, the valuation picture now looks closer to fair than clearly cheap, with the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples both pointing to pricing that is roughly in line with the fundamentals. Over the last three years, Xylem shares are up 14.5%, which is a solid but not spectacular return for investors who have stayed in the stock. Future cash flow growth from Xylem's...

PJT Partners has delivered a very strong 142.3% share price return over the past five years, yet the stock now screens as only fairly valued on an intrinsic value basis while still looking inexpensive on some earnings multiples and carrying a low overall value score. The 142.3% return over five years highlights how much of PJT Partners' earlier upside has already been realised, so fresh gains may depend on whether earnings and cash flows keep pace with expectations. Recent headlines around...

The Simply Good Foods Company recently reported that third-quarter fiscal 2026 sales fell to US$356.98 million from US$380.96 million a year earlier, with the business moving from a US$41.10 million net profit to a US$51.97 million net loss and posting losses for the first nine months as well. Alongside these weaker results, management cut net sales guidance for both the fourth quarter and full fiscal 2026, even as it completed a multi-year buyback that retired 16.11% of shares for US$344.93...

The Eli Lilly move on AtaiBeckley has pushed psychedelics and mental health treatments back into the spotlight, and it is giving investors fresh reasons to reassess which stocks are most exposed to this news. With a multi billion dollar cash deal, a premium offer, and a late stage DMT program now under a big pharma umbrella, attention is turning to other companies tied to similar themes. This article breaks down three stocks from our mental health and psychedelic treatments screener that...

AECOM has secured several major infrastructure roles in Australia, Canada, and the UK. The company will act as Independent Certifier for The Wave rail project in Queensland. It has been appointed lead designer for the Alexandra Bridge replacement in Ottawa. AECOM is also the exclusive design partner for an upgrade to Thames Water’s Oxford treatment facility. AECOM (NYSE:ACM) is taking on new responsibilities across rail, bridge, and water infrastructure at a time when its stock is trading...

Elevance Health (ELV) has released its Q2 2026 numbers, reporting revenue of about US$50.5b, basic EPS of US$6.71 and net income of US$1,463m. The trailing twelve months show revenue of roughly US$201.1b, EPS of US$22.53 and net income of US$4,963m. Over recent quarters the company has seen revenue move from US$49.8b in Q2 2025 to US$50.5b in Q2 2026. Over the same period, quarterly basic EPS shifted from US$7.74 to US$6.71 and net income from US$1,743m to US$1,463m, setting the backdrop for...

Federal Reserve Chair Kevin Warsh’s first testimony has put monetary policy, inflation, and central bank independence back at the center of market conversations, and large cap U.S. financial stocks sit close to that action. When Fed policy is in focus, some companies can find their business models better aligned with the new playbook, while others may face tougher conditions. This article explains how the latest Fed signals and the ongoing inflation debate relate to large U.S. financials. It...

Bank of New York Mellon Corporation (BNY) opened Q2 2026 with revenue of US$5.7 billion and basic EPS of US$2.47, alongside trailing twelve month revenue of US$21.4 billion and basic EPS of US$8.66 that sit on top of a 26% earnings growth rate over the past year. The company has seen revenue move from US$18.8 billion and EPS of US$6.18 on a trailing basis in Q1 2025 to US$21.4 billion and EPS of US$8.66 by Q2 2026, while net income climbed from US$4.53 billion to US$6.02 billion over the same...

Conagra Brands (CAG) has capped FY 2026 with fourth quarter revenue of US$2,882.1 million and basic EPS of a US$3.37 loss, as trailing twelve month figures show revenue of US$11.3 billion and basic EPS of a US$4.00 loss. Over recent periods the company has seen quarterly revenue move between US$2,632.6 million and US$2,979.1 million, while basic EPS has shifted from profits of US$0.54 in FY 2025 Q4 to losses in FY 2026 Q2 and Q4. For investors, the latest results put the focus on how Conagra...

Aehr Test Systems (AEHR) has wrapped up FY 2026 with fourth quarter revenue of US$18.8 million and EPS of US$0.04, compared with revenue of US$14.1 million and EPS of US$0.10 loss in the prior year’s fourth quarter, while the latest trailing twelve months show revenue of US$50.0 million and an EPS loss of US$0.23. Over the past six reported quarters, the company has seen quarterly revenue range between US$9.9 million and US$18.8 million, with EPS moving between a loss of US$0.11 and a profit...

Political uncertainty around President Trump’s election-focused address, the proposed SAVE America Act, and Iran war concerns is putting fresh attention on U.S. defense and security stocks. When policy priorities, funding paths, and public sentiment all feel up in the air, investors often reassess which companies might be positioned to benefit or face added risk. This article looks at three U.S. Defense and Security Stocks from our screener that appear more positively exposed to the current...